SIGNIFOR pasireotide 900 microgram/1 mL (as diaspartate) solution for injection ampoule オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 900 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 1128.6 microgram (equivalent: pasireotide, qty 900 microgram) - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; tartaric acid - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 300 microgram/1 mL (as diaspartate) solution for injection ampoule オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 300 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 376.2 microgram (equivalent: pasireotide, qty microgram) - injection, solution - excipient ingredients: water for injections; mannitol; tartaric acid; sodium hydroxide - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 600 microgram/1 mL (as diaspartate) solution for injection ampoule オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 600 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 752.4 microgram (equivalent: pasireotide, qty 600 microgram) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; tartaric acid; mannitol - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

CYSTADANE betaine 1g/g oral powder bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

cystadane betaine 1g/g oral powder bottle

recordati rare diseases australia pty ltd - betaine, quantity: 1 g/g - powder, oral - excipient ingredients: - as an adjunct in the treatment of homocystinuria.

Zanidip 20mg tablets イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

zanidip 20mg tablets

lexon (uk) ltd - lercanidipine hydrochloride - oral tablet - 20mg

Betaloc 1 mg/ml solution for injection アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

betaloc 1 mg/ml solution for injection

recordati ireland limited - metoprolol tartrate - solution for injection - 1 milligram(s)/millilitre - beta blocking agents, selective; metoprolol

Livazo tablets film-coated アルメニア - 英語 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

livazo tablets film-coated

recordati industria chimica e farmaceutica s.p.a. - pitavastatin (pitavastatin calcium) - tablets film-coated - 4mg

Zanidip 10 mg film-coated tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

zanidip 10 mg film-coated tablets

pco manufacturing ltd. - lercanidipine hydrochloride - film-coated tablet - 10 milligram(s) - dihydropyridine derivatives; lercanidipine

Zanidip 20 mg film-coated tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

zanidip 20 mg film-coated tablets

pco manufacturing ltd. - lercanidipine hydrochloride - film-coated tablet - 20 milligram(s) - dihydropyridine derivatives; lercanidipine

URISPAS 200 TABLET 200 mg シンガポール - 英語 - HSA (Health Sciences Authority)

urispas 200 tablet 200 mg

dch auriga singapore - flavoxate hcl - tablet, film coated - 200 mg - flavoxate hcl 200 mg